A. S. Levey and J. Coresh, Chronic kidney disease, Lancet, vol.379, pp.165-80, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02445392

K. Mccullough, P. Sharma, T. Ali, I. Khan, W. Smith et al., Measuring the population burden of chronic kidney disease: a systematic literature review of the estimated prevalence of impaired kidney function, Nephrol Dial Transplant, vol.27, pp.1812-1833, 2012.

G. Assogba, C. Couchoud, C. Roudier, C. Pornet, S. Fosse et al., screening and treatment of chronic kidney disease in people with type 2 diabetes in France: the ENTRED surveys, Diabetes Met, vol.38, pp.558-66, 2001.

Q. Zhang and D. Rothenbacher, Prevalence of chronic kidney disease in population-based studies: systematic review, BMC Public Health, vol.8, p.117, 2008.

N. Lameire, K. Jager, W. Van-biesen, D. De-bacquer, and R. Vanholder, Chronic kidney disease: a European perspective, Kidney Int, vol.68, pp.30-38, 2005.

C. B. Bowling, J. N. Booth, O. M. Gutiérrez, K. Tamura, M. Huang et al., Non disease-specific problems and all-cause mortality among older adults with CKD: The REGARDS Study, Clin J Am Soc Nephrol, vol.9, pp.1737-1782, 2014.

D. S. Keith, G. A. Nichols, C. M. Gullion, J. Betz-brown, and D. Smith, Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization, Arch Intern Med, vol.164, pp.659-63, 2004.

R. N. Foley, A. M. Murray, S. Li, C. A. Herzog, A. M. Mcbean et al., Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United states Medicare population, J Am Soc Nephrol, vol.16, pp.489-95, 1998.

R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke et al., Chronic kidney disease as cause of cardiovascular morbidity and mortality, Nephrol Dial Transplant, vol.20, pp.1048-56, 2005.

G. As, G. M. Chertow, D. Fan, C. E. Mcculloch, and C. Y. Hsu, Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization, N Engl J Med, vol.351, pp.1296-305, 2004.

A. J. Collins, S. Li, D. T. Gilbertson, J. Liu, S. C. Chen et al., Chronic kidney disease and cardiovascular disease in the Medicare population, Kidney Int, vol.87, pp.24-31, 2003.

A. M. O'hare, A. I. Choi, D. Bertenthal, P. Bacchetti, A. X. Garg et al., Age affects outcomes in chronic kidney disease, J Am Soc Nephrol, vol.18, pp.2758-65, 2007.

C. Jones, P. Roderick, S. Harris, and M. Rogerson, Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease, Nephrol Dial Transplant, vol.21, pp.2133-2176, 2006.

P. J. Roderick, R. J. Atkins, L. Smeeth, D. M. Nitsch, R. B. Hubbard et al., Detecting chronic kidney disease in older people; what are the implications?, Age Ageing, vol.37, pp.179-86, 2008.

B. R. Hemmelgarn, J. Zhang, B. J. Manns, M. T. James, R. R. Quinn et al., for the Alberta Kidney Disease Network. Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate, JAMA, vol.303, pp.1151-58, 2010.

S. I. Hallan, K. Dahl, C. M. Oien, D. C. Grootendorst, A. Aasberg et al., Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey, BMJ, vol.333, p.1047, 2006.

A. Innes, The detection of advanced chronic kidney disease by surveillance of elevated plasma creatinines -a five-year experience, Nephrol Dial Transplant, vol.23, pp.2571-75, 2008.

A. Akbary, P. J. Swedko, H. D. Clark, W. Hogg, J. Lemelin et al., Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program, Arch Intern Med, vol.164, pp.1788-92, 2004.

N. Richards, K. Harris, M. Whitfield, D. O'donoghue, R. Lewis et al., The impact of population-based identification of chronic kidney disease using estimated glomerular filtration rate (eGFR) reporting, Nephrol Dial Transplant, vol.23, pp.556-61, 2008.

A. K. Bello, J. Peters, J. Wight, D. De-zeeuw, E. Nahas et al., A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS), Am J Kidney Dis, vol.52, pp.434-477, 2008.

D. C. Grootendorst, K. J. Jager, C. Zoccali, and F. W. Dekker, Screening: why, when, and how, Kidney Int, vol.76, pp.694-703, 2009.

H. C. Rayner, J. Baharani, I. Dasgupta, V. Suresh, R. M. Temple et al., Does community-wide chronic kidney disease management improve patient outcomes?, Nephrol Dial Transplant, vol.29, pp.644-653, 2014.

R. Minutolo, F. Lapi, P. Chiodini, M. Simonetti, E. Bianchini et al., Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study, Clin J Am Soc Nephrol, vol.9, pp.1586-93, 2014.

A. S. Levey, J. Coresh, T. Greene, L. A. Stevens, Y. L. Zhang et al., Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate, Ann Intern Med, vol.145, pp.247-54, 2006.

K. Doqi, clinical practice guidelines for chronic kidney disease evaluation, classification, and stratification. Kidney Disease Outcomes Quality Initiative, Am J Kidney Dis, vol.39, pp.1-266, 2002.

C. Couchoud, B. Stengel, P. Landais, J. C. Aldigier, F. De-cornelissen et al., The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France, Nephrol Dial Transplant, vol.21, pp.411-419, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00452918

I. Registre-décès, , 2016.

I. Recensement, , 1999.

, HFA-DB) WHO regional office for Europe, 2014.

J. D. Kalbfleisch and R. L. Prentice, The statistical analysis of failure time data, Series in probability and statistics, pp.247-77, 2002.

R. L. Prentice, J. D. Kalbfleisch, A. Peterson, N. Flournoy, V. T. Farewell et al., The analysis of failure times in the presence of competing risks, Biometrics, vol.34, pp.541-54, 1978.

H. Putter, M. Fiocco, and R. B. Geskus, Tutorial in biostatistics: competing risks and multi-state models, Stat Med, vol.26, pp.2389-430, 2007.

A. Latouche, A. Allignol, J. Beyersmann, M. Labopin, and J. P. Fine, A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions, J Clin Epidemiol, vol.66, pp.648-53, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00794995

S. Van-buuren and K. Groothuis-oudshoorn, MICE: Multivariate Imputation by Chained Equations in R, J Stat Softw, vol.45, pp.1-67, 2011.

A. Marshall, D. Altman, and R. Holder, Comparison of imputation methods for handling missing covariate data when fitting a Cox proportional hazards model: a resampling study, BMC Med Res Methodol, vol.10, p.112, 2010.

A. M. Wood, I. R. White, and P. Royston, How should variable selection be performed with multiply imputed data, Stat Med, vol.27, pp.3227-3273, 2008.

D. B. Rubin, Multiple imputation after 18+ years, J Am Stat Assoc, vol.91, pp.473-89, 1996.

T. Therneau, P. Gramsch, and T. Fleming, Martingale-based residuals for survival models, Biometrika, vol.77, pp.147-60, 1990.

, R Foundation for Statistical Computing. R Development Core Team, 2010.

N. Drey, P. Roderick, M. Mullee, and M. Rogerson, A population-based study of the incidence and outcomes of diagnosed chronic kidney disease, Am J Kidney Dis, vol.42, pp.677-84, 2003.

A. D. Rule, R. J. Rodeheffer, T. S. Larson, J. C. Burnett, F. G. Cosio et al., Limitations of estimating glomerular filtration rate from serum creatinine in the general population, Mayo Clin Proc, vol.81, pp.1427-1461, 2006.

N. Richards, K. Harris, M. Whitfield, D. O'donoghue, R. Lewis et al., Primary care-based disease management of chronic kidney disease (CKD), based on estimated glomerular filtration rate (eGFR) reporting, improves patient outcomes, Nephrol Dial Transplant, vol.23, pp.549-55, 2008.

Y. Xie, B. Bowe, H. Xian, S. Balasubramanian, and Z. Al-aly, Estimated GFR trajectories of people entering CKD stage 4 and subsequent kidney disease outcomes and mortality, Am J Kidney Dis, 2016.

S. D. Navaneethan, J. D. Schold, S. Arrigain, S. E. Jolly, N. Jr et al., Cause-specific deaths in non-dialysis-dependent CKD, J Am Soc Nephrol, vol.26, pp.2512-2532, 2015.

S. Mandelli, E. Riva, M. Tettamanti, P. Detoma, A. Giacomin et al., Mortality prediction in the oldest old with five different equations to estimate glomerular filtration rate : the health and anemia population-based study, PLoS One, 2015.

B. Faller, J. B. Beuscart, and L. Frimat, Association des néphrologues de l'Est. Competingrisk analysis of death and dialysis initiation among elderly (?80 years) newly referred to nephrologists: a French prospective study, BMC Nephrol, vol.14, p.103, 2013.

, ANAES : Diagnostic de l'insuffisance rénale chronique chez l'adulte. Recommandations, 2002.

, ANAES : Moyens thérapeutiques pour ralentir la progression de l'insuffisance rénale chronique chez l'adulte, 2006.

E. Crowe, D. Halpin, and P. Stevens, on behalf of the Guideline Development Group. Early identification and management of chronic kidney disease: summary of NICE guidance, BMJ, vol.337, p.1530, 2008.

, National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, vol.39, pp.1-266, 2002.

J. C. Verhave, R. T. Gansevoort, H. L. Hillege, S. J. Bakker, D. De-zeeuw et al., An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population, Kidney Int Suppl, vol.92, pp.18-21, 2004.

J. C. Peterson, S. Adler, J. M. Burkart, T. Greene, L. A. Hebert et al., Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study, Ann Intern Med, vol.123, pp.754-62, 1995.

W. F. Keane, Z. Zhang, P. A. Lyle, M. E. Cooper, D. De-zeeuw et al., RENAAL Study Investigators. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study, Clin J Am Soc Nephrol, vol.1, pp.761-768, 2006.

K. Iseki, H. Uehara, K. Nishime, K. Tokuyama, K. Yoshihara et al., Impact of the initial levels of laboratory variables on survival in chronic dialysis patients, Am J Kidney Dis, vol.28, pp.541-549, 1996.

K. Iseki, K. Kinjo, C. Iseki, and S. Takishita, Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis, vol.44, pp.806-820, 2004.

H. C. Gerstein, J. F. Mann, Q. Yi, B. Zinman, S. F. Dinneen et al., HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals, JAMA, vol.286, pp.421-427, 2001.

R. C. Atkins, E. M. Briganti, J. B. Lewis, L. G. Hunsicker, G. Braden et al., Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy, Am J Kidney Dis, vol.45, pp.281-288, 2005.

T. H. Jafar, P. C. Stark, C. H. Schmid, M. Landa, G. Maschio et al., Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease, Kidney Int, vol.60, pp.1131-1171, 2001.

P. Ruggenenti, A. Perna, G. Remuzzi, and . Gisen-group, Retarding progression of chronic renal disease: the neglected issue of residual proteinuria, Kidney Int, vol.63, pp.2254-61, 2003.

S. Araki, M. Haneda, D. Koya, H. Hidaka, T. Sugimoto et al., Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes, Diabetes, vol.56, pp.1727-1757, 2007.

D. M. Kent, T. H. Jafar, R. A. Hayward, H. Tighiouart, M. Landa et al., Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease, J Am Soc Nephrol, vol.18, pp.1959-65, 2007.

M. T. James, B. R. Hemmelgarn, and M. Tonelli, Early recognition and prevention of chronic kidney disease, Lancet, vol.375, pp.1296-309, 2010.

, HAS: Moyens thérapeutiques pour ralentir la progression de l'insuffisance rénale chronique chez l'adulte, 2004.

V. Agrawal, A. K. Ghosh, M. A. Barnes, and P. A. Mccullough, Perception of indications for nephrology referral among internal medicine residents: a national online survey, Clin J Am Soc Nephrol, vol.4, pp.323-331, 2009.

R. F. Charles, N. R. Powe, B. G. Jaar, M. U. Troll, R. S. Parekh et al., Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians, Am J Kidney Dis, vol.54, pp.227-264, 2009.

H. Wasse and W. M. Mcclellan, Increasing physician knowledge about the diagnosis and management of CKD: how can we help primary care providers?, Am J Kidney Dis, vol.54, pp.187-90, 2009.

L. A. Stevens, G. Fares, J. Fleming, D. Martin, K. Murthy et al., Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease, J Am Soc Nephrol, vol.16, pp.2439-2487, 2005.

B. A. Cooper, P. Branley, L. Bulfone, J. F. Collins, J. C. Craig et al., IDEAL Study: A randomized, controlled trial of early versus late initiation of dialysis, N Engl J Med, vol.363, pp.609-628, 2010.

M. Kessler, L. Frimat, V. Panescu, and S. Briançon, Impact of nephrology referral on early and midterm outcomes in ESRD: EPidémiologie de l'Insuffisance REnale chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study, Am J Kidney Dis, vol.42, pp.474-85, 2003.

B. M. Sohel, N. Rumana, M. Ohsawa, T. C. Turin, and M. A. Kelly, Al Mamun M. Renal function trajectory over time and adverse clinical outcomes, Clin Exp Nephrol, 2016.

R. J. Glassock, Referrals for chronic kidney disease. Real problem or nuisance?, JAMA, vol.303, pp.1201-1204, 2010.

, The Renal Association. Treatment of adult patients with renal failure. Recommended standards and audit measures, pdf?sfvrsn=0. Accessed 29, 1997.